Literature DB >> 24160696

Role of hepatic efflux transporters in regulating systemic and hepatocyte exposure to xenobiotics.

Nathan D Pfeifer1, Rhiannon N Hardwick, Kim L R Brouwer.   

Abstract

Hepatic efflux transporters include numerous well-known and emerging proteins localized to the canalicular or basolateral membrane of the hepatocyte that are responsible for the excretion of drugs into the bile or blood, respectively. Altered function of hepatic efflux transporters due to drug-drug interactions, genetic variation, and/or disease states may lead to changes in xenobiotic exposure in the hepatocyte and/or systemic circulation. This review focuses on transport proteins involved in the hepatocellular efflux of drugs and metabolites, discusses mechanisms of altered transporter function as well as the interplay between multiple transport pathways, and highlights the importance of considering intracellular unbound concentrations of transporter substrates and/or inhibitors. Methods to evaluate hepatic efflux transport and predict the effects of impaired transporter function on systemic and hepatocyte exposure are discussed, and the sandwich-cultured hepatocyte model to evaluate comprehensively the role of hepatic efflux in the hepatobiliary disposition of xenobiotics is characterized.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24160696     DOI: 10.1146/annurev-pharmtox-011613-140021

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  28 in total

1.  Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques.

Authors:  Charles S Venuto; Marianthi Markatou; Yvonne Woolwine-Cunningham; Rosemary Furlage; Andrew J Ocque; Robin DiFrancesco; Emily O Dumas; Paul K Wallace; Gene D Morse; Andrew H Talal
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

2.  Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis.

Authors:  B C Ferslew; C K Johnston; E Tsakalozou; A S Bridges; M F Paine; W Jia; P W Stewart; A S Barritt; K L R Brouwer
Journal:  Clin Pharmacol Ther       Date:  2015-03-15       Impact factor: 6.875

3.  Intrahepatic Sampling for the Elucidation of Antiviral Clinical Pharmacology.

Authors:  Charles S Venuto; Andrew H Talal
Journal:  Clin Pharmacol Drug Dev       Date:  2017-03

4.  Role of multidrug resistance-associated protein 4 in the basolateral efflux of hepatically derived enalaprilat.

Authors:  Brian C Ferslew; Kathleen Köck; Arlene S Bridges; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2014-06-23       Impact factor: 3.922

Review 5.  Quantitative targeted proteomics for membrane transporter proteins: method and application.

Authors:  Xi Qiu; Hui Zhang; Yurong Lai
Journal:  AAPS J       Date:  2014-05-15       Impact factor: 4.009

Review 6.  Disruption of small molecule transporter systems by Transporter-Interfering Chemicals (TICs).

Authors:  Sascha C T Nicklisch; Amro Hamdoun
Journal:  FEBS Lett       Date:  2020-12-09       Impact factor: 4.124

7.  A Genome-wide Association Study Discovers 46 Loci of the Human Metabolome in the Hispanic Community Health Study/Study of Latinos.

Authors:  Elena V Feofanova; Han Chen; Yulin Dai; Peilin Jia; Megan L Grove; Alanna C Morrison; Qibin Qi; Martha Daviglus; Jianwen Cai; Kari E North; Cathy C Laurie; Robert C Kaplan; Eric Boerwinkle; Bing Yu
Journal:  Am J Hum Genet       Date:  2020-10-07       Impact factor: 11.025

8.  Glycyrrhizin has a high likelihood to be a victim of drug-drug interactions mediated by hepatic organic anion-transporting polypeptide 1B1/1B3.

Authors:  Jiajia Dong; Olajide E Olaleye; Rongrong Jiang; Jing Li; Chuang Lu; Feifei Du; Fang Xu; Junling Yang; Fengqing Wang; Weiwei Jia; Chuan Li
Journal:  Br J Pharmacol       Date:  2018-07-23       Impact factor: 8.739

Review 9.  Colorectal cancers and chlorinated water.

Authors:  Ahmed Mahmoud El-Tawil
Journal:  World J Gastrointest Oncol       Date:  2016-04-15

Review 10.  Prediction of pharmacokinetics and drug-drug interactions when hepatic transporters are involved.

Authors:  Rui Li; Hugh A Barton; Manthena V Varma
Journal:  Clin Pharmacokinet       Date:  2014-08       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.